Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATE for De Novo AML in Young Patients
NCT00005793Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jul 1999
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in acute myeloid leukemia (AML), sponsored by Moffitt Cancer Center. Started Jul 1999; status: completed.
02
Drugs
topotecan
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00005793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005793.